Safety and Feasibility of Soractelite Transperineal Focal Laser Ablation for Prostate Cancer and Short-term Quality of Life Analysis from a Multicenter Pilot Study
Open Access
- 2 April 2022
- journal article
- research article
- Published by Elsevier in European Urology Open Science
- Vol. 39, 48-54
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Phase II Evaluation of Magnetic Resonance Imaging Guided Focal Laser Ablation of Prostate CancerJournal of Urology, 2016
- Focal Laser Ablation of Prostate Cancer: Phase I Clinical TrialJournal of Urology, 2016
- Focal Therapy in Prostate Cancer: International Multidisciplinary Consensus on Trial DesignEuropean Urology, 2014
- MR Imaging–guided Focal Laser Ablation for Prostate Cancer: Phase I TrialRadiology, 2013
- Focal Laser Ablation for Prostate Cancer Followed by Radical Prostatectomy: Validation of Focal Therapy and Imaging AccuracyEuropean Urology, 2010
- Image Guided Photothermal Focal Therapy for Localized Prostate Cancer: Phase I TrialJournal of Urology, 2009
- No surgical innovation without evaluation: the IDEAL recommendationsThe Lancet, 2009
- Quality of Life and Satisfaction with Outcome among Prostate-Cancer SurvivorsNew England Journal of Medicine, 2008
- Systematic Review: Comparative Effectiveness and Harms of Treatments for Clinically Localized Prostate CancerAnnals of Internal Medicine, 2008
- Comprehensive Comparison of Health-Related Quality of Life After Contemporary Therapies for Localized Prostate CancerJournal of Clinical Oncology, 2002